Correction: Novel antibodies detect additional &#945;-synuclein pathology in synucleinopathies: potential development for immunotherapy.

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.

Nimmo, Jacqui T; Verma, Ajay; Dodart, Jean-Cosme; Wang, Chang Yi; Savistchenko, Jimmy; Melki, Ronald; Carare, Roxana O; Nicoll, James A R.

Afiliação

Nimmo JT; Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Verma A; United Neuroscience, Dublin, Republic of Ireland.
Dodart JC; United Neuroscience, Dublin, Republic of Ireland.
Wang CY; United Neuroscience, Dublin, Republic of Ireland.
Savistchenko J; Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Paris, France.
Melki R; Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Paris, France.
Carare RO; Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Nicoll JAR; Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. J.Nicoll@soton.ac.uk.

Alzheimers Res Ther ; 15(1): 18, 2023 Jan 21.

Article em En | MEDLINE | ID: mdl-36681823

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article